Lin TT - Search Results

1

Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.

Pan ZZ, Wang HY, Zhang M, Lin TT, Zhang WY, Zhao PF, Tang YS, Xiong Y, Zeng YE, Huang YZ. Pan ZZ, et al. Among authors: lin tt. Acta Pharmacol Sin. 2016 Aug;37(8):1110-20. doi: 10.1038/aps.2016.48. Epub 2016 Jun 13. Acta Pharmacol Sin. 2016. PMID: 27292613 Free PMC article.

2

A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging.

Wang Y, Lin T, Zhang W, Jiang Y, Jin H, He H, Yang VC, Chen Y, Huang Y. Wang Y, et al. Theranostics. 2015 Apr 6;5(8):787-95. doi: 10.7150/thno.11139. eCollection 2015. Theranostics. 2015. PMID: 26000052 Free PMC article.

3

Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides.

Lin T, Liu E, He H, Shin MC, Moon C, Yang VC, Huang Y. Lin T, et al. Acta Pharm Sin B. 2016 Jul;6(4):352-8. doi: 10.1016/j.apsb.2016.04.001. Epub 2016 May 26. Acta Pharm Sin B. 2016. PMID: 27471676 Free PMC article.

4

Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.

Lin T, Zhao P, Jiang Y, Tang Y, Jin H, Pan Z, He H, Yang VC, Huang Y. Lin T, et al. ACS Nano. 2016 Nov 22;10(11):9999-10012. doi: 10.1021/acsnano.6b04268. Epub 2016 Nov 8. ACS Nano. 2016. PMID: 27934069

5

Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis.

Tang Y, Liang J, Wu A, Chen Y, Zhao P, Lin T, Zhang M, Xu Q, Wang J, Huang Y. Tang Y, et al. ACS Appl Mater Interfaces. 2017 Aug 16;9(32):26648-26664. doi: 10.1021/acsami.7b05292. Epub 2017 Aug 3. ACS Appl Mater Interfaces. 2017. PMID: 28741923

6

Correction to Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis.

Tang Y, Liang J, Wu A, Chen Y, Zhao P, Lin T, Zhang M, Xu Q, Wang J, Huang Y. Tang Y, et al. ACS Appl Mater Interfaces. 2020 Jan 15;12(2):3275. doi: 10.1021/acsami.9b21975. Epub 2019 Dec 31. ACS Appl Mater Interfaces. 2020. PMID: 31889434 No abstract available.

7

Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages.

Lin TT, Xiong W, Chen GH, He Y, Long L, Gao XF, Zhou JL, Lv WW, Huang YZ. Lin TT, et al. Acta Pharmacol Sin. 2024 Apr;45(4):867-878. doi: 10.1038/s41401-023-01205-4. Epub 2023 Dec 19. Acta Pharmacol Sin. 2024. PMID: 38114644

8

Left Atrial Dimension and CHA₂DS₂-VASc Score in Predicting Stroke in Patients with Rheumatic Atrial Fibrillation.

Chang SN, Wang CH, Waranugraha Y, Lin TT, Chen JJ, Huang PS, Wu CK, Wang YC, Hwang JJ, Tsai CT. Chang SN, et al. Among authors: lin tt. JACC Adv. 2024 Oct 30;3(12):101343. doi: 10.1016/j.jacadv.2024.101343. eCollection 2024 Dec. JACC Adv. 2024. PMID: 39817065 Free PMC article.

9

Inhibition of NETs prevents doxorubicin-induced cardiotoxicity by attenuating IL-18-IFN-γ-Cx43 axis induced cardiac conduction abnormalities.

Li K, Jiang KM, Wang Y, Hu F, Zhu XC, Sun CL, Jin L, Liu WT, Lin TT, Li M. Li K, et al. Among authors: lin tt. Int Immunopharmacol. 2025 Jan 12;147:114016. doi: 10.1016/j.intimp.2025.114016. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39805175

10

Correction: Silver(I)-iodine cluster with efficient thermally activated delayed fluorescence and suppressed concentration quenching.

Li X, Wei SY, Zhang DH, Hu JX, Hou CL, Lin TT, Chen XL, Lu CZ. Li X, et al. Among authors: lin tt. Dalton Trans. 2025 Jan 21;54(4):1711. doi: 10.1039/d5dt90008e. Dalton Trans. 2025. PMID: 39801282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters